Skip to main content

Featured

Ontario Auto Insurance Just Changed: What Every Driver Needs to Know Before July 1

  If you drive in Ontario, this affects you — starting July 1, 2026 , the biggest shake-up to Ontario's auto insurance system in decades is here. Nine benefits that were automatically included in every policy for years are now optional extras you have to pay for separately — or go without. The Ford government is calling it consumer choice. Critics are calling it a coverage cliff. Either way, Ontario drivers need to understand what just changed before their next policy renewal — because the default "basic" plan is now much leaner than what you're used to. From Standard Package to À La Carte Ontario's auto insurance has always included a bundle of Statutory Accident Benefits (SABs) — no-fault coverage that kicks in when you're hurt in a collision, regardless of who caused it. Think income replacement, caregiver support, funeral costs. They were simply part of the deal. That changes now. Starting July 1, 2026, only three categories of benefits remain mandatory in...

article

A Silent Trend in Canadian Long‑Term Care: Antipsychotic Use Without Diagnosis

 

A recent report has revealed a troubling pattern in long‑term care (LTC) homes across Canada: one in four residents is being given antipsychotic medication despite having no diagnosis of psychosis. These drugs—intended to treat conditions involving delusions or hallucinations—are often being used instead to manage behavioural symptoms such as aggression or agitation, particularly among residents with dementia. 

This trend has been growing in recent years. National data shows that potentially inappropriate antipsychotic use in LTC reached more than 24% in 2023–2024, continuing an upward trajectory that began before the COVID‑19 pandemic. Rates vary widely across the country, with some jurisdictions approaching 35%. The pandemic intensified staffing shortages and disrupted person‑centred care practices, making it harder for facilities to rely on non‑pharmacological approaches. 

Canada’s rate of inappropriate antipsychotic use is also high by international standards—nearly two and a half times the rate reported in the United States, and significantly higher than in countries like Australia and Sweden. 

Advocates and health organizations stress that antipsychotics should not be the first line of response for dementia‑related behaviours. Instead, they call for renewed investment in staffing, training, and person‑centred care strategies that address the root causes of agitation without relying on powerful medications.

As Canada continues to grapple with an aging population, the findings highlight an urgent need to strengthen oversight, support caregivers, and ensure that seniors receive safe, appropriate, and dignified care.


Comments